[
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007708"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "neoantigen DNA vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007708",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that may enhance anti-tumor immune response in Renal Cell Carcinoma in combination with checkpoint inhibitors ipilimumab (anti-CTLA-4 antibody) and nivolumab (anti-PD-1 antibody)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005494",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007660"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005494",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007660"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005494",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007660",
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0005505"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005494",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007660",
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0005505"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007709"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "neoantigen peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007709",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of patient-specific antigens, which are immunogenic and unique to the patient's tumor, with potential immunomodulating and antineoplastic activities. The neoantigen peptide vaccine, the peptides stimulate the host immune system to mount a specific cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis. Personalized neo-antigen peptide vaccine is a product combines multiple patient specific neo-antigens. Given personalized neo-antigen peptide vaccine together with Th1 polarizing adjuvant poly ICLC may induce a polyclonal, poly-epitope, cytolytic T cell immunity against the patient's tumor. Patients also receive nivolumab."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007710"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "neoantigen synthetic long peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007710",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of synthetic long peptides (SLPs), ranging from 20-35 amino acids in size, that are derived from two or more of the patient's tumor-specific mutant antigens (TSMAs), with potential immunostimulatory and antitumor activities. SLP vaccine may stimulate the host immune system to mount a cytotoxic T-cell lymphocyte (CTL)-mediated immune response against the TSMAs expressed by the tumor cells. This vaccine is a optimized neoantigen synthetic long peptide (SLP) vaccines for pancreatic cancer patients following neoadjuvant chemotherapy. The neoantigen SLP vaccines will incorporate prioritized neoantigens and will be co-administered with poly-ICLC. It can be used in combination with chemoradiation with temozolomide for patients with newly diagnosed glioblastoma."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007711"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "neoantigen-loaded autologous dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007711",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of autologous DCs loaded with immunogenic peptides derived from autologous cancer cells, with potential immunomodulating and antineoplastic activities. Vaccination with the neoantigen-loaded autologous DC vaccine stimulates the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing the neoantigens, which results in tumor cell lysis. Neoantigens arising from the mutations of the tumor genome expressed specifically on the tumor cell instead of normal cells, suggesting that vaccines targeting neoantigens should generate a highly tumor-specific response with minimal off-target effects. Neoantigens are identified from tumor tissues from a gastric cancer, hepatocellular carcinoma, lung cancer or colorectal cancer patient. Dendritic cells are then primed with synthesized peptides. The vaccine can be combined with microwave ablation ti treat patients with Hepatocellular Carcinoma (HCC). It can also be combined with Anti-PD1 (Nivolumab) as for patients with resected Hepatocellular Carcinoma (HCC) and Liver Metastases From Colorectal Cancer (CRLM). "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007712"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "NY-ESO-1, MAGE-A1, and MAGE-A3 dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007712",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine that is made from the subject's blood cells and is designed to interact in the patient's body with cells that are programmed to fight specific tumor proteins NY-ESO-1, Melanoma Antigen Gene-A1 (MAGE-A1) and Melanoma Antigen Gene-A3 (MAGE-A3). The vaccine can be given in combination with decitabine which may increase the amount and activity of these cancer proteins on the surface of tumor cells to increase the possibility that the vaccine will stimulate cells to act against the tumor cells. The dendritic cells may stimulate CD4 and CD8 antigen specific T cells in patients with relapsed or refractory pediatric high grade gliomas, medulloblastomas, and central nervous system primitive neuroectodermal tumors (CNS PNETs)."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: NY-ESO-1|Gene name: MAGE-A1|Gene name: MAGE-A3"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007713"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "NY-ESO-1/PRAME/MAGE-A3/WT-1 peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007713",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine comprised of synthetic peptides derived from the cancer-testis antigen NY-ESO-1, preferentially expressed antigen in melanoma (PRAME), human melanoma antigen A3 (MAGE-A3) and the human Wilms tumor protein-1 (WT-1), with potential immunostimulating and antineoplastic activities. NY-ESO-1/PRAME/MAGE-A3/WT-1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing NY-ESO-1, PRAME, MAGE-A3 and WT-1, resulting in tumor cell lysis. As proteins are degraded in cells, peptides are presented on the surface of these cells as a complex with tissue type molecules (HLA molecules). T-cells may then recognize the peptide-HLA complexes, via its T-cell receptor, potentially resulting in tumor-cell killing, if sufficient priming takes place. Cancer testis antigens (CTA's) are known to be immunogenic and are only expressed at immunoprivileged sites, thus out of reach of immune responses, and on cancer cells, making them ideal targets for therapeutic cancer vaccination. The CTA's chosen were NY-ESO-1, MAGE-A3 and PRAME. WT-1 is additionally included as this protein has proven to be an important antigen in hematological malignancies. It is combined with azacitidine for treatment of patients with high-risk myelodysplastic syndrome or acute myeloid leukemia. "
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: NY-ESO-1|Gene name: PRAME|Gene name: MAGE-A3|Gene name: WT-1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007714"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "OCDC and NeoDC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007714",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made with autologous DCs that are pulsed with HOCl-oxidized autologous tumor lysate (OCDC) and administered in prime phase, along with a personal neoantigen-sensitized DC(NeoDC) vaccine administered in the boost phase for Esophageal Squamous Cell Carcinoma."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005496",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005496",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005496",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005496",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007715"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "oral cancer vaccine V3-OVA"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007715",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine composed of autologous ovarian cancer antigens obtained from hydrolyzed, inactivated blood and tumor tissue of patients with ovarian cancer, with potential immunostimulatory and antineoplastic activities. The ovarian cancer antigens stimulate the immune system and activate a cytotoxic T-lymphocyte (CTL) immune response against ovarian cancer cells. Ovarian cancer patients can be given one pill a day for three months. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005493",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005493",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005493",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005493",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007716"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "oral therapeutic vaccine V3-X"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007716",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of the tumor-associated antigen (TAA) oligosaccharide antigen sialyl Lewis A (CA19-9; sialylated Lewis A antigen; carbohydrate antigen 19-9; cancer antigen 19-9), with potential immunostimulating and antineoplastic activities. Oral therapeutic vaccine V3-X induces a cytotoxic T-lymphocyte (CTL)-mediated immune response against tumor cells expressing CA19-9. Cholangiocarcinoma (CCA) is a malignant neoplasm originating from the epithelial cells lining the intra- or extrahepatic biliary ducts. This immunotherapeutic formulation is made from pooled heat- and chemically-inactivated blood from donors with CCA for a pill for cholangiocarcinoma patients."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/VO_0007657",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/VO_0007657",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007717"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "P30-linked EphA2/CMV pp65/survivin peptide vaccine P30-EPS"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007717",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine comprised of three immunogenic tetanus toxoid epitope P30-linked tumor-associated antigen (TAA) peptides, P30-linked Ephrin receptor A2 (EphA2), P30-linked cytomegalovirus (CMV) matrix protein pp65 (65 kDa lower matrix phosphoprotein; UL83) and P30-linked survivin, with potential immunostimulating and antineoplastic activities. The vaccine may elicit a cytotoxic T-lymphocyte (CTL) response against tumor cells expressing EphA2, CMV pp65 and survivin. Hiltonol is used as an adjuvant to stimulate or enhance the activation of your immune system. The vaccine and adjuvant may help treat HLA-A*0201 positive patients with a newly diagnosed, unmethylated, and untreated World Health Organization (WHO) grade IV malignant glioma."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: EphA2|Gene name: survivin"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005428",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007718"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "P501-AS15 vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007718",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made up of CPC-P501 protein formulated with the adjuvant AS15. Patients with hormone-sensitive prostate cancer and rising PSA, after primary tumor treatment, can be treated with the P501-AS15 vaccine. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007719"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "pancreatic tumor personalized neoantigen vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007719",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine based on next-generation sequencing and major histocompatibility complex affinity prediction algorithm, which may help treat patients with pancreatic ductal adenocarcinoma. This vaccine may elicit measurable neoantigen-specific immunologic responses in patients."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005430",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005430",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005430",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005430",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007720"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PD-L1 peptide vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007720",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine composed of a peptide derived from the tumor-associated antigen (TAA) and immune checkpoint molecule programmed cell death-1 ligand 1 (PD-L1) combined with the immunoadjuvant montanide ISA-51, with potential immunomodulating and antineoplastic activities. Vaccination with PD-L1 peptide vaccine may activate the immune system to induce an immune response against PD-L1-expressing cells. This may increase and restore the proliferation and activation of various immune cells, including cytotoxic T-lymphocytes (CTLs), and may eradicate PD-L1-expressing tumor cells. The vaccines aims to stimulate PD-L1 specific T-cells, hence eliminating both PD-L1 positive tumor cells as well as PD-L1 positive immunosuppressive and antigen presenting cells in the tumor microenvironment. It has been used in clinical trials for patients with multiple melanoma."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: PD-L1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007721"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PD-L1/IDO peptide vaccine IO102-103"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007721",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine composed of IO103, a peptide derived from the tumor-associated antigen (TAA) programmed cell death-1 ligand 1 (PD-L1), IO102, the 21-mer peptide vaccine derived from the immunomodulatory enzyme indoleamine 2,3-dioxygenase (IDO), and the immunoadjuvant montanide ISA-51, with potential immunomodulating and antineoplastic activities. Both IDO and PD-L1 reactive CD8 T cells are cytotoxic and can kill cancer cells and immune regulatory cells in vitro. Thus boosting specific T cells that recognize immune regulatory proteins such as IDO and PD-L1 may directly modulate immune regulation. The the programmed death 1 (PD-1) regulatory antibody Nivolumab may further help treat patients with metastatic melanoma."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: PD-L1|Gene name: IDO"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007722"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "personal neoantigen cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007722",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine designed to target the unique immunogenic mutations arising in each patient's tumor. Peptide binding to MHC is a critical gateway to both the initiation of a T-cell immune response by the antigen presenting cell (APC), and to the detection and elimination of tumor cells presenting the particular peptide by the stimulated cytotoxic T lymphocyte (CTL). The attraction of neoantigens as cancer targets for the immune system results from the structural and geographical features of the mutation. Neoantigen peptides are only found in tumor cells, so CTLs should show exquisite specificity, reducing the opportunity for autoimmune disease."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007723"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "personalized follicular lymphoma vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007723",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine co-administered with poly-ICLC, nivolumab, and rituximab (or another monoclonal antibody against CD20) to treat Follicular Lymphoma. The peptides comprising the vaccine are reconstituted in up to 4 pools with 5 peptides per pool (A, B, C, and D)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005427",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007724"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "personalized mature dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007724",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that may stimulate the immune system to react to lung cancer cells, in combination with Cyclophosphamide."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005486",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007725"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "personalized neoantigen melanoma vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007725",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine for melanoma. Melanomas have mutations (changes in genetic material) that are specific to an individual patient and tumor. These mutations can cause the tumor cells to produce proteins that appear very different from the body's own cells. These proteins used in a vaccine may induce strong immune responses, which may help the participant's body fight any tumor cells that could cause the melanoma to come back in the future. NeoVax is a long-peptide vaccine targeting up to 20 personal neoantigens per patient for patients with surgically resected stage IIIB/C or IVM1a/b melanoma. There was long-term persistence of neoantigen-specific T cell responses following vaccination, with ex vivo detection of neoantigen-specific T cells exhibiting a memory phenotype, as well as diversification of neoantigen-specific T cell clones over time, with emergence of multiple T cell receptor clonotypes exhibiting distinct functional avidities. There was also tumor infiltration by neoantigen-specific T cell clones after vaccination and epitope spreading, suggesting on-target vaccine-induced tumor cell killing. Personal neoantigen peptide vaccines thus induce T cell responses that persist over years and broaden the spectrum of tumor-specific cytotoxicity in patients with melanoma. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007726"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "PolyPEPI1018 CRC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007726",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine that contains 6 synthetic peptides mixed with the adjuvant Montanide. The peptides were selected to induce T cell responses against 12 dominant epitopes from 7 cancer testis antigens (CTAs), which are the most frequently expressed CTAs in colorectal cancer. The 6 peptides were optimized to induce long lasting CRC specific T cell responses. Colorectal cancer peptide vaccine PolyPEPI1018 potentially elicits a cytotoxic T-lymphocyte response against colorectal tumors expressing the CTAs associated with the vaccine, which may result in a reduction in tumor cell proliferation. "
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: CTAG1B"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005426",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005426",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005426",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005426",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007727"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "polyvalent melanoma vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007727",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of whole irradiated heterologous melanoma cells which express multiple melanoma-related antigens. Polyvalent melanoma vaccine may stimulate an antitumoral cytotoxic T-cell immune response in the host, resulting in inhibition of tumor cell proliferation and tumor cell death. Vaccines may make the body build an immune response and kill tumor cells. Interleukin-2 may stimulate a person's white blood cells to kill tumor cells. Interferon alfa-2b may interfere with the growth of tumor cells. Treatment with this combination may help treat melanoma. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007728"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "prodencel"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007728",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made with autologous dendritic cells targeting prostate cancer (PC)-specific antigen(s), with potential immunostimulatory and antineoplastic activities. Upon administration of prodencel, the DCs stimulate a specific cytotoxic T-lymphocyte (CTL)-mediated immune response against PC cells expressing the antigen(s), resulting in tumor cell lysis. (NCIT_C192174) The vaccine could help treat patients with metastatic castration-resistant prostate cancer (mCRPC) after novel androgen-deprived therapy and docetaxel chemotherapy failure."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005425",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007729"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "pUMVC3-IGFBP2-HER2-IGF1R plasmid DNA vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007729",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine containing the mammalian expression vector pUMVC3 encoding epitopes derived from three tumor-associated antigens (TAAs): human insulin-like growth factor-binding protein 2 (IGFBP2), human epidermal growth factor receptor 2 (HER2; ERBB2) and insulin-like growth factor 1 receptor (IGF1R), with potential immunostimulating and antineoplastic activities. The vaccine This activates the immune system to mount a combined response from specific T helper type 1 (Th1) cells, memory T-cells and cytotoxic T-lymphocytes (CTL) against IGFBP2-, HER2-, and IGF1R-expressing tumor cells. This vaccine may prevent cancer from coming back in patients with non-metastatic, node positive, human epidermal growth factor receptor (HER)2 negative breast cancer in which all signs and symptoms have disappeared. Vaccines made from deoxyribonucleic acid (DNA) may help the body build an effective immune response to kill tumor cells. It is given in combination with sargramostim."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: IGFBP2|Gene name: HER2|Gene name: IGF1R"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007660"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007660"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007660",
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0005505"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005484",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007660",
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0005505"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007730"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "RAS peptide cancer vaccine TG01"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007730",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine containing seven 17 amino acids long synthetic RAS oncogene-encoded peptides representing the most common codon 12 and 13 oncogenic mutations in Kirsten rat sarcoma viral oncogene homolog (KRAS), with potential immunomodulating and antineoplastic activities. The vaccine may stimulate a specific CD4-positivehelper T-lymphocyte- and cytotoxic T-lymphocyte (CTL)-mediated immune response against RAS mutant-specific-expressing cancer cells, resulting in an inhibition of tumor cell proliferation and tumor cell death. The vaccine can be given in combination with Balstilimab and QS-21 for patients with pancreatic cancer to increase efficacy. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005430",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0005430",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005430",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0005430",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007731"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "SCIB1 DNA vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007731",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine that encodes a melanoma antigen tyrosinase-related protein 2 (TRP2) cytotoxic T-lymphocyte (CTL) epitope and a modified monoclonal antibody, a chimera of human IgG1/murine IgG2a with T cell mimotopes expressed within the complementarity-determining regions (CDR) of the antibodies, with potential immunostimulating and antineoplastic activities. The melanoma TRP2 CTL epitope vaccine SCIB1 expresses the modified antibody. Subsequently, the Fc component of the engineered antibody targets and binds to the CD64 receptor on the dendritic cells (DCs); upon processing by DCs, the cellular immune system may be activated to induce helper T-cell and CTL immune responses against tumor cells expressing the TRP2 antigen. SCIB1 can be used in combination with either nivolumab (Opdivo) with ipilimumab (Yervoy) or pembrolizumab (Keytruda), standard treatments approved for patients with advanced melanoma."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: TRP-2"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007660"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007660"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007660",
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0005505"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007660",
      "http://purl.obolibrary.org/obo/VO_0000032",
      "http://purl.obolibrary.org/obo/VO_0005505"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007732"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "secPD-L1 vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007732",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made with secPD-L1, a splice variant of PD-L1 (programmed death ligand-1, an immune checkpoint pathway) that does not splice into the transmembrane domain, but instead produces a secreted form of PD-L1 that has a unique 18 amino acid tail containing a cysteine that allows it to homodimerize and more effectively inhibit lymphocyte function than monomeric soluble PD-L1. Recombinant secPD-L1 can dimerize and inhibit T-cell proliferation and IFN-gamma production in vitro. SecPD-L1 may function as a paracrine negative immune regulator within the tumor, since secPD-L1 does not require a cell-to-cell interaction to mediate its inhibitory effect. This could lead to improved survival for patients with numerous types of cancers, including lung cancer, melanoma, renal cell carcinoma, and Hodgkin lymphoma."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: PD-L1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007733"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "sialyl lewis-keyhole limpet hemocyanin conjugate vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007733",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that consists of the oligosaccharide antigen sialyl Lewis (CA19-9) conjugated to the nonspecific immunomodulator keyhole limpet hemocyanin (KLH), with potential antineoplastic activity. The sialyl Lewis-keyhole limpet hemocyanin conjugate vaccine may induce production of IgG and IgM antibodies as well as trigger an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells expressing the sialyl Lewis antigen. The vaccine therapy together with QS21 may cause a stronger immune response and kill more tumor cells. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000195",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000195",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000195",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000195",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007734"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "tetanus peptide melanoma vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007734",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth. This vaccine is compromised of multi-epitope melanoma peptide vaccine (12MP) and 1 tetanus peptide melanoma vaccine emulsified with GM-CSF and ISA-51 (incomplete Freund's adjuvant)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000422",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000577",
      "http://purl.obolibrary.org/obo/VO_0000534",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007735"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "TGF2 antisense-GMCSF gene modified autologous tumor cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007735",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made with GMCSF transgene that directly stimulates increased expression of tumor antigen(s) and enhances dendritic cell migration to the vaccination site. TGF2 blockade following intracellular TGF2 antisense gene expression reduces production of immune inhibiting activity at the vaccine site. This vaccine integrates enhancement of an anticancer immune response concurrently with a reduction in cancer-induced immune suppression. Autologous cancer cells are harvested from patients with advanced refractory cancer, and a TGF2 antisense / GMCSF expression vector plasmid is constructed. The autologous cancer tissue is irradiated and electrocorporated with the vector. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007736"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "total tumor RNA-loaded dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007736",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine containing autologous dendritic cells (DCs) that are loaded with total tumor RNA (TTRNA) from a specific tumor, with potential immunostimulatory and antineoplastic activities. The vaccine may elicit a highly specific cytotoxic T-cell (CTL) response against the tumor-associated antigens (TAAs) encoded by the TTRNA. The vaccine can be given in combination with Temozolomide (TMZ) and Autologous Hematopoietic Stem Cells (HSC)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007737"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "transgenic lymphocyte immunization vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007737",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine made as patient's lymphocytes are rendered transgenic for a gene coding for selected portion of telomerase an enzyme expressed in the vast majority of cancer cells. Transgenic cells are then returned to the patient to produce an immune response targeted at cancer cells expressing telomerase. The transgenic cells serve as antigen- presenting cells (APCs) with the dual function of antigen synthesis and presentation. Vaccination produces an immune response targeting cancer cells expressing telomerase."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: telomerase"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007738"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "TriAd cancer vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007738",
    "type": [
      "class",
      "entity"
    ],
    "definition": [
      {
        "type": [
          "literal"
        ],
        "value": "A cancer vaccine of 3 adenoviral vaccines (ETBX-011, ETBX-051 & ETBX-061). ETBX-011 uses a replication-defective, E1- and E2b-deleted oncolytic adenoviral serotype 5 (Ad5) encoding an epitope of human carcinoembryonic antigen (CEA). ETBX-051 is composed of a replication-defective, serotype 5 adenovirus (Ad5) with the viral genes early 1 (E1), early 2b (E2b), and early 3 (E3) deleted, and the human transcription factor brachyury encoded. ETBX-061 composed of a replication-defective, serotype 5 adenovirus (Ad5) with the viral genes early 1 (E1), early 2b (E2b), and early 3 (E3) deleted, and the human glycoprotein mucin 1 (MUC1) encoded. The three of these vaccines act against tumor associated antigens and have potential immunostimulating and antineoplastic activities. The TriAd vaccine can be used in combination with Anti-PD-L1/TGF-beta trap (M7824) and Anktiva (N-803) to shrink previously untreated head and neck tumors before surgery or stop the tumors from coming back after all treatment."
      },
      {
        "type": [
          "literal"
        ],
        "value": "Gene name: CEA|Gene name: brachyury|Gene name: MUC1"
      }
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0007657"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000484",
      "http://purl.obolibrary.org/obo/VO_0005505",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000550"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007739"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "tumor antigen-sensitized DC vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007739",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that can be used in combination with Neo-antigen DC vaccine and their sensitized T cells for the treatment of esophageal cancer, advanced malignant melanoma, bladder cancer and colorectal cancer."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007740"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "tumor lysate-pulsed dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007740",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine that is composed of dendritic cells pulsed with tumor cells lysates that stimulate a potent and specific cell mediated anti-tumor immune response. It can be used in combination with high-dose chemotherapy and hematopoietic stem cell transplantation (HSCT). The combination may increase overall survival and progression-free survival for patients with high-risk pediatric and young adult tumors (localized solid tumors such as, sarcoma, neuroblastoma, and Wilms' tumor). "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007741"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "tumor lysate/KLH pulsed dendritic cell vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007741",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made from proteins from the patient's tumor cells may boost the body's immune response against the tumor. The effects of chemotherapy on the immune system can potentially make immunotherapy more effective if administered soon after completion of chemotherapy. The addition of recombinant human IL-7 (interleukin 7) (rhIL-7 (recombinant human interleukin 7)) may make the immunotherapy more effective. Alpha cluster of differentiation 25 (CD25) and 8H9 depleted autologous lymphocytes plus tumor lysate/keyhole limpet hemocyanin (KLH) pulsed dendritic cell vaccines plus or minus r-hIL7 (CYT107) may induce immune responses to tumor lysate in patients (with Ewing's sarcoma, rhabdomyosarcoma or neuroblastoma)."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005495",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005495",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005495",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005495",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007742"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "TVI-Brain-1 vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007742",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine made as the patient's cancer will be surgically removed to provide cells for the vaccine, then the patient will be vaccinated twice with those cells and GM-CSF. After, the patient's blood will be filtered for white cells which will then be cultured and stimulated to reach a higher (killer) activity level. Next, the activated white blood cells will be infused into the patient's bloodstream so that they will be able to attack the cancer. Lastly, the entire process starting with vaccination will be repeated, for a total of two rounds of therapy. The autologous vaccine-enhanced ex vivo activated cancer neoantigens-specific T-cells TVI-Brain-1 recognize and bind to tumor cells expressing the cancer neoantigens, resulting in a cytotoxic T-lymphocyte (CTL)-mediated immune response against the patient's tumor cells."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007743"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "whole tumor cell-based leukemia vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007743",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A cancer vaccine administered within the first 2 to 3 months after allogeneic stem cell transplantation may enhance graft-vs.-leukemia responses. Irradiated autologous cancer cells provide a source of tumor antigens at the vaccination site. Granulocyte macrophage colony-stimulating factor (GM-CSF) secreted by irradiated bystander cells stimulates the recruitment, maturation and immunostimulatory activity of dendritic cells (DCs) at the vaccination site. Autologous whole tumor cell-based vaccination may tip the balance between leukemia-specific and alloreactive T cell responses in favor of a graft-vs.-leukemia (GvL) effect."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0005487",
      "http://purl.obolibrary.org/obo/VO_0000177",
      "http://purl.obolibrary.org/obo/VO_0005503",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0007657",
      "http://purl.obolibrary.org/obo/VO_0000550",
      "http://purl.obolibrary.org/obo/VO_0007658"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007747"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "authorized vaccine role"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007747",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "Vaccine role that indicates a vaccine has received emergency use authorization (EUA) from regulatory authorities for distribution and administration to the public."
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/VO_0000615",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/VO_0000615",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000615",
      "http://purl.obolibrary.org/obo/BFO_0000023",
      "http://purl.obolibrary.org/obo/BFO_0000017",
      "http://purl.obolibrary.org/obo/BFO_0000020",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000615",
      "http://purl.obolibrary.org/obo/BFO_0000023",
      "http://purl.obolibrary.org/obo/BFO_0000017",
      "http://purl.obolibrary.org/obo/BFO_0000020",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007748"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "USA licensed veterinary vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007748",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "USA licensed vaccine for veterinary uses approved by USDA. "
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": "http://purl.obolibrary.org/obo/VO_0001485",
    "hasHierarchicalParents": true,
    "hierarchicalParent": "http://purl.obolibrary.org/obo/VO_0001485",
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001485",
      "http://purl.obolibrary.org/obo/VO_0000363",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001485",
      "http://purl.obolibrary.org/obo/VO_0000363",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001"
    ],
    "hasDirectChildren": true,
    "numDescendants": 794,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 794,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0007749"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "licensed duck vaccine"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0007749",
    "type": [
      "class",
      "entity"
    ],
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0000657",
      "http://purl.obolibrary.org/obo/VO_0001469"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0000657",
      "http://purl.obolibrary.org/obo/VO_0001469"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000657",
      "http://purl.obolibrary.org/obo/VO_0000363",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0001461",
      "http://purl.obolibrary.org/obo/VO_0001218",
      "http://purl.obolibrary.org/obo/VO_0001469"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0000657",
      "http://purl.obolibrary.org/obo/VO_0000363",
      "http://purl.obolibrary.org/obo/VO_0000001",
      "http://purl.obolibrary.org/obo/OBI_0000047",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0001461",
      "http://purl.obolibrary.org/obo/VO_0001218",
      "http://purl.obolibrary.org/obo/VO_0001469"
    ],
    "hasDirectChildren": true,
    "numDescendants": 3,
    "hasHierarchicalChildren": true,
    "numHierarchicalDescendants": 3,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010000"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Crptosporidium parvum Cp12"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010000",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A Cp12 protein that is part of Crptosporidium parvum"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010001"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Crptosporidium parvum Cp21"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010001",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A Cp21 protein that is part of Crptosporidium parvum"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010002"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Crptosporidium parvum Cp15"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010002",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A Cp15 protein that is part of Crptosporidium parvum"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010003"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Crptosporidium parvum CP60"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010003",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A CP60 protein that is part of Crptosporidium parvum"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010004"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Crptosporidium parvum Cp23"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010004",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A Cp23 protein that is part of Crptosporidium parvum"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010005"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Crptosporidium parvum CpP2"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010005",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A CpP2 protein that is part of Crptosporidium parvum"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010842"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010842",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010006"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Eimeria acervulina 3-1E"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010006",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A 3-1E protein that is part of Eimeria acervulina"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010822"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010822"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010822",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010822",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010007"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Eimeria maxima gam56"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010007",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A gam56 protein that is part of Eimeria maxima"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010833"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010833"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010833",
      "http://purl.obolibrary.org/obo/VO_0010822",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010833",
      "http://purl.obolibrary.org/obo/VO_0010822",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010009"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Giardia  duodenalis a1-giardin"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010009",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A a1-giardin protein that is part of Giardia  duodenalis"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010829"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0010829"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010829",
      "http://purl.obolibrary.org/obo/VO_0005477",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0010829",
      "http://purl.obolibrary.org/obo/VO_0005477",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010010"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Giardia  lamblia a1-giardin"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010010",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A a1-giardin protein that is part of Giardia  lamblia"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0015483"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0015483"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0015483",
      "http://purl.obolibrary.org/obo/VO_0010829",
      "http://purl.obolibrary.org/obo/VO_0005477",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0015483",
      "http://purl.obolibrary.org/obo/VO_0010829",
      "http://purl.obolibrary.org/obo/VO_0005477",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  },
  {
    "curie": {
      "type": [
        "literal"
      ],
      "value": "VO:0010011"
    },
    "label": {
      "type": [
        "literal"
      ],
      "value": "Giardia  lamblia alpha-enolase"
    },
    "iri": "http://purl.obolibrary.org/obo/VO_0010011",
    "type": [
      "class",
      "entity"
    ],
    "definition": {
      "type": [
        "literal"
      ],
      "value": "A alpha-enolase protein that is part of Giardia  lamblia"
    },
    "isObsolete": false,
    "hasDirectParents": true,
    "directParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0015483"
    ],
    "hasHierarchicalParents": true,
    "hierarchicalParent": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/VO_0015483"
    ],
    "directAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0015483",
      "http://purl.obolibrary.org/obo/VO_0010829",
      "http://purl.obolibrary.org/obo/VO_0005477",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hierarchicalAncestor": [
      "http://purl.obolibrary.org/obo/VO_0001232",
      "http://purl.obolibrary.org/obo/OBI_1110034",
      "http://purl.obolibrary.org/obo/BFO_0000040",
      "http://purl.obolibrary.org/obo/BFO_0000004",
      "http://purl.obolibrary.org/obo/BFO_0000002",
      "http://purl.obolibrary.org/obo/BFO_0000001",
      "http://purl.obolibrary.org/obo/VO_0015483",
      "http://purl.obolibrary.org/obo/VO_0010829",
      "http://purl.obolibrary.org/obo/VO_0005477",
      "http://purl.obolibrary.org/obo/VO_0010755",
      "http://purl.obolibrary.org/obo/PR_000000001",
      "http://purl.obolibrary.org/obo/CHEBI_23367",
      "http://purl.obolibrary.org/obo/CHEBI_24431"
    ],
    "hasDirectChildren": false,
    "numDescendants": 0,
    "hasHierarchicalChildren": false,
    "numHierarchicalDescendants": 0,
    "isPreferredRoot": false
  }
]